Max-delbrück-centrum Für Molekulare Medizin In Der Hemlholtz-gemeinschaft
1 patent in portfolio
- US11643468utility2023Chimeric Antigen Receptors and CAR-T Cells That Bind CXCR5 and Methods of Use Thereof to Treat Medical Disorders0 cites
1 patent in portfolio